219 related articles for article (PubMed ID: 36594016)
41. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Ambrosio S; Saccà CD; Majello B
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
[TBL] [Abstract][Full Text] [Related]
42. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.
Hu X; Li X; Valverde K; Fu X; Noguchi C; Qiu Y; Huang S
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10141-6. PubMed ID: 19497860
[TBL] [Abstract][Full Text] [Related]
43. LSD1: Expanding Functions in Stem Cells and Differentiation.
Martinez-Gamero C; Malla S; Aguilo F
Cells; 2021 Nov; 10(11):. PubMed ID: 34831474
[TBL] [Abstract][Full Text] [Related]
44. Targeting the GFI1/1B-CoREST Complex in Acute Myeloid Leukemia.
van Bergen MGJM; van der Reijden BA
Front Oncol; 2019; 9():1027. PubMed ID: 31649884
[TBL] [Abstract][Full Text] [Related]
45. Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.
Dai XJ; Liu Y; Xue LP; Xiong XP; Zhou Y; Zheng YC; Liu HM
J Med Chem; 2021 Mar; 64(5):2466-2488. PubMed ID: 33619958
[TBL] [Abstract][Full Text] [Related]
46. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.
Zheng YC; Duan YC; Ma JL; Xu RM; Zi X; Lv WL; Wang MM; Ye XW; Zhu S; Mobley D; Zhu YY; Wang JW; Li JF; Wang ZR; Zhao W; Liu HM
J Med Chem; 2013 Nov; 56(21):8543-60. PubMed ID: 24131029
[TBL] [Abstract][Full Text] [Related]
47. Lysine-Specific Demethylase 1 (LSD1) epigenetically controls osteoblast differentiation.
Rummukainen P; Tarkkonen K; Dudakovic A; Al-Majidi R; Nieminen-Pihala V; Valensisi C; Hawkins RD; van Wijnen AJ; Kiviranta R
PLoS One; 2022; 17(3):e0265027. PubMed ID: 35255108
[TBL] [Abstract][Full Text] [Related]
48. Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.
Song Y; Zhang H; Yang X; Shi Y; Yu B
Eur J Med Chem; 2022 Jan; 228():114042. PubMed ID: 34915312
[TBL] [Abstract][Full Text] [Related]
49. A hypomorphic lsd1 allele results in heart development defects in mice.
Nicholson TB; Singh AK; Su H; Hevi S; Wang J; Bajko J; Li M; Valdez R; Goetschkes M; Capodieci P; Loureiro J; Cheng X; Li E; Kinzel B; Labow M; Chen T
PLoS One; 2013; 8(4):e60913. PubMed ID: 23637775
[TBL] [Abstract][Full Text] [Related]
50. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
[TBL] [Abstract][Full Text] [Related]
51. 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.
Kutz CJ; Holshouser SL; Marrow EA; Woster PM
Medchemcomm; 2014 Dec; 5(12):1863-1870. PubMed ID: 25580204
[TBL] [Abstract][Full Text] [Related]
52. LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.
Takagi S; Ishikawa Y; Mizutani A; Iwasaki S; Matsumoto S; Kamada Y; Nomura T; Nakamura K
Cancer Res; 2017 Sep; 77(17):4652-4662. PubMed ID: 28667074
[TBL] [Abstract][Full Text] [Related]
53. Pilocarpine-induced seizures associate with modifications of LSD1/CoREST/HDAC1/2 epigenetic complex and repressive chromatin in mice hippocampus.
Noches V; Rivera C; González MP; Merello G; Olivares-Costa M; Andrés ME
Biochem Biophys Rep; 2021 Mar; 25():100889. PubMed ID: 33426312
[TBL] [Abstract][Full Text] [Related]
54. Involvement of histone demethylase LSD1 in short-time-scale gene expression changes during cell cycle progression in embryonic stem cells.
Nair VD; Ge Y; Balasubramaniyan N; Kim J; Okawa Y; Chikina M; Troyanskaya O; Sealfon SC
Mol Cell Biol; 2012 Dec; 32(23):4861-76. PubMed ID: 23028048
[TBL] [Abstract][Full Text] [Related]
55. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
Liang Y; Quenelle D; Vogel JL; Mascaro C; Ortega A; Kristie TM
mBio; 2013 Feb; 4(1):e00558-12. PubMed ID: 23386436
[TBL] [Abstract][Full Text] [Related]
56. LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.
Barth J; Abou-El-Ardat K; Dalic D; Kurrle N; Maier AM; Mohr S; Schütte J; Vassen L; Greve G; Schulz-Fincke J; Schmitt M; Tosic M; Metzger E; Bug G; Khandanpour C; Wagner SA; Lübbert M; Jung M; Serve H; Schüle R; Berg T
Leukemia; 2019 Jun; 33(6):1411-1426. PubMed ID: 30679800
[TBL] [Abstract][Full Text] [Related]
57. Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A.
Macfarlan TS; Gifford WD; Agarwal S; Driscoll S; Lettieri K; Wang J; Andrews SE; Franco L; Rosenfeld MG; Ren B; Pfaff SL
Genes Dev; 2011 Mar; 25(6):594-607. PubMed ID: 21357675
[TBL] [Abstract][Full Text] [Related]
58. LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer Transcription.
Scionti I; Hayashi S; Mouradian S; Girard E; Esteves de Lima J; Morel V; Simonet T; Wurmser M; Maire P; Ancelin K; Metzger E; Schüle R; Goillot E; Relaix F; Schaeffer L
Cell Rep; 2017 Feb; 18(8):1996-2006. PubMed ID: 28228264
[TBL] [Abstract][Full Text] [Related]
59. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells.
Ishikawa Y; Gamo K; Yabuki M; Takagi S; Toyoshima K; Nakayama K; Nakayama A; Morimoto M; Miyashita H; Dairiki R; Hikichi Y; Tomita N; Tomita D; Imamura S; Iwatani M; Kamada Y; Matsumoto S; Hara R; Nomura T; Tsuchida K; Nakamura K
Mol Cancer Ther; 2017 Feb; 16(2):273-284. PubMed ID: 27903753
[TBL] [Abstract][Full Text] [Related]
60. Lysine-specific demethylase 1 expression in zebrafish during the early stages of neuronal development.
Li A; Sun Y; Dou C; Chen J; Zhang J
Neural Regen Res; 2012 Dec; 7(34):2719-26. PubMed ID: 25337119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
